A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Clinical trial NCT05042362 · COMPLETED

Trial details

NCT number: NCT05042362
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vasomotor Symptoms Associated With Menopause Hot Flashes

Start date: 2021-08-27
Primary completion: 2023-07-25
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.